Cargando…
2019–2020 Drug Updates in Solid Tumors
During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hanna also discussed signs and symptoms of potential serious and li...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087241/ https://www.ncbi.nlm.nih.gov/pubmed/34084574 http://dx.doi.org/10.6004/jadpro.2021.12.3.11 |
_version_ | 1783686632021426176 |
---|---|
author | Hanna, Kirollos S. |
author_facet | Hanna, Kirollos S. |
author_sort | Hanna, Kirollos S. |
collection | PubMed |
description | During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hanna also discussed signs and symptoms of potential serious and life-threatening adverse events, and how new therapeutic entities will impact the advanced practice setting. |
format | Online Article Text |
id | pubmed-8087241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Harborside Press LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-80872412021-06-02 2019–2020 Drug Updates in Solid Tumors Hanna, Kirollos S. J Adv Pract Oncol Meeting Reports During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hanna also discussed signs and symptoms of potential serious and life-threatening adverse events, and how new therapeutic entities will impact the advanced practice setting. Harborside Press LLC 2021-04 2021-04-01 /pmc/articles/PMC8087241/ /pubmed/34084574 http://dx.doi.org/10.6004/jadpro.2021.12.3.11 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Reports Hanna, Kirollos S. 2019–2020 Drug Updates in Solid Tumors |
title | 2019–2020 Drug Updates in Solid Tumors |
title_full | 2019–2020 Drug Updates in Solid Tumors |
title_fullStr | 2019–2020 Drug Updates in Solid Tumors |
title_full_unstemmed | 2019–2020 Drug Updates in Solid Tumors |
title_short | 2019–2020 Drug Updates in Solid Tumors |
title_sort | 2019–2020 drug updates in solid tumors |
topic | Meeting Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087241/ https://www.ncbi.nlm.nih.gov/pubmed/34084574 http://dx.doi.org/10.6004/jadpro.2021.12.3.11 |
work_keys_str_mv | AT hannakirolloss 20192020drugupdatesinsolidtumors |